Efficacy of flecainide in a patient with catecholaminergic polymorphic ventricular tachycardia.
Biernacka
Elzbieta Katarzyna
EK
Department of Congenital Heart Diseases, Institute of Cardiology, Alpejska 42, 04906 Warsaw, Poland. kbiernacka@ikard.pl
Hoffman
Piotr
P
D058671:Adrenergic beta-1 Receptor Antagonists / Q000627:therapeutic use; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D017298:Bisoprolol / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D005424:Flecainide / Q000627:therapeutic use*; D006801:Humans; D017180:Tachycardia, Ventricular / Q000188:drug therapy / Q000503:physiopathology; D016896:Treatment Outcome; D000098850:Polymorphic Catecholaminergic Ventricular Tachycardia
D058671:Adrenergic beta-1 Receptor Antagonists; D000889:Anti-Arrhythmia Agents; D005424:Flecainide; D017298:Bisoprolol